MaxCmin1 Trial Group
Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial
Tillmann H, Lundgren J, Dragsted U, Hill A, Vernazza P, Monforte A, Antunes F, Staszewski S, Fox Z, Kaiser T, MaxCmin1 Trial Group. Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial. Journal of acquired immune deficiency syndromes (1999) 2005; 40:378-80.
01.11.2005Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial
01.11.2005Journal of acquired immune deficiency syndromes (1999) 2005; 40:378-80
Tillmann Hans L, Lundgren Jens D, Dragsted Ulrik B, Hill Andrew, Vernazza Pietro, Monforte Antonella d'Arminio, Antunes Francesco, Staszewski Schlomo, Fox Zoe, Kaiser Thorsten, MaxCmin1 Trial Group
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial
Dragsted U, Lundgren J, Fox Z, Youle M, Vernazza P, Cassetti I, Hill A, Benetucci J, Bruun J, Clumeck N, Cahn P, Castagna A, Obel N, Duran A, Peters B, Pedersen C, Gerstoft J, MaxCmin1 Trial Group. Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial. The Journal of infectious diseases 2003; 188:635-42.
01.09.2003Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial
01.09.2003The Journal of infectious diseases 2003; 188:635-42
Dragsted Ulrik Bak, Lundgren Jens D, Fox Zoe, Youle Mike, Vernazza Pietro, Cassetti Isabel, Hill Andrew, Benetucci Jorge, Bruun Johan N, Clumeck Nathan, Cahn Pedro, Castagna Antonella, Obel Niels, Duran Adriana, Peters Barry, Pedersen Court, Gerstoft Jan, MaxCmin1 Trial Group